SCHEMBL6307694

SCHEMBL6307694

CC(C)(C)OC(=O)N(N)C1CC(=O)c2cccc3[nH]cc(c23)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 6/20 0.43
HTR1A P08908 6/20 0.43
HTR2B P41595 6/20 0.43
HTR6 P50406 6/20 0.43
HTR7 P34969 5/20 0.43
HTR2C P28335 4/20 0.43
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
KDM4E B2RXH2 3/20 0.42
MAPT P10636 2/20 0.42
RECQL P46063 2/20 0.42
USP2 O75604 1/20 0.42
PLEC Q15149 1/20 0.42
DRD3 P35462 6/20 0.40
DRD2 P14416 5/20 0.40
DRD4 P21917 5/20 0.40
HRH1 P35367 5/20 0.40
ADRB2 P07550 4/20 0.40
ADRB1 P08588 4/20 0.40
DRD5 P21918 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6311706 0.78 PARP1 (0.48) HTR2AHTR1AHTR2BHTR6HTR7
SCHEMBL26101730 0.67 HTR2A (0.44) HTR2AHTR1AHTR2BHTR6HTR7
SCHEMBL19216639 0.65 PARP1 (0.43) HTR2AHTR1AHTR2BHTR6HTR7
SCHEMBL5286055 0.65 NPY5R (0.41) HTR1ADRD2
SCHEMBL29913528 0.65 KDM4E (0.85) HTR2AHTR1AHTR2BHTR6HTR7
SCHEMBL28838236 0.65 KDM4E (0.85) HTR2AHTR1AHTR2BHTR6HTR7
SCHEMBL762909 0.65 CRBN (0.47) MEN1KMT2AKDM4EMAPTRECQL
SCHEMBL6304417 0.65 MTNR1A (0.44) HTR2AHTR1AHTR2BHTR6HTR7
SCHEMBL261487 0.63 PARP1 (0.64) HTR1AHTR2BHTR6HTR7MEN1
SCHEMBL5278104 0.63 HSD11B1 (0.44) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050043387-A1 Tricyclic indole compounds having an affinity against serotonin receptors FUKUI YOSHIKAZU (JP) 2005-02-24 US disclosed
US-6858640-B2 Tricyclic indole compounds having affinity for serotonin receptor SHIONOGI & CO., LTD. (JP) 2005-02-22 US disclosed
US-20030236295-A1 Tricylic indole compounds having affinity for serotonin receptor SHIONOGI & CO., LTD. (JP) 2003-12-25 US disclosed
EP-1325909-A1 TRICYCLIC INDOLE COMPOUNDS HAVING AFFINITY FOR SEROTONIN RECEPTOR SHIONOGI & CO., LTD. (JP) 2003-07-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043387-A1 Tricyclic indole compounds having an affinity against serotonin receptors HTR4, TPH1, HRH4 HTR2A 15/4885HTR1A 6/4885HTR2B 21/4885
US-20030236295-A1 Tricylic indole compounds having affinity for serotonin receptor HTR4, HRH4, TPH1 HTR2A 20/4885HTR1A 7/4885HTR2B 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.